Clinical and Radiographic Evaluation of Bioceramic Putty MTA Versus MTA in Pulpotomy of Immature Permanent Molars
Trial statusNot yet recruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age6-8
SponsorCairo University
About this trial
The present study aims to evaluate the clinical and radiographic success of bioceramics putty MTA versus MTA in the pulpotomy of immature permanent molars
The main question it aims to answer is:
Will the biocermaics putty MTA have higher clinical and radiographic success rates than MTA in pulpotomy of immature permanent molars?
Eligibility criteria
Qualifiers
Patients aged from 6-8 years of both sexes have immature permanent molars
with deep carious lesions indicated for pulpotomy.
Restorable young permanent molars with no clinical symptoms of irreversible pulpitis.
Permanent molars without any clinical sign of pulp necrosis including swelling, fistula, pain on percussion, and pathologic tooth mobility.
Disqualifiers
Medically compromised patients who have systemic disease.
Uncooperative patients who refuse treatment.
Permanent molars that were previously restored.
Trial design
Treatments tested in this trial
- premixed Bio-ceramic MTA
- Conventional MTA
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov